Altus Biologics Incorporated Company Profile

News Articles [508 Associated News Articles listed on BioPortfolio]

Altus Capital Partners buys ChoiceSpine

Altus Capital Partners has paid an undisclosed amount for spinal fusion hardware and biologics company ChoiceSpine.  -More- 

Altus Power Acquires Sponsor Member Interests in Solar Tax Equity Partnership

GREENWICH, Conn., Jan. 8, 2019 /PRNewswire/ -- Altus Power America, Inc. with its subsidiaries ("Altus Power") has successfully completed the acquisition of sponsor member shares Read more...

ChoiceSpine scooped up by Altus Capital

Altus Capital Partners is buying closely held spinal device maker ChoiceSpine, LP for an undisclosed sum.

Altus Capital completes second acquisition in medical technology industry

Based in Knoxville, Tennessee, ChoiceSpine designs, manufactures and markets spinal implants, instrumentation and biologies for surgical treatment of complex spine disorders. It was founded in 2006. ...

Altus Capital Partners, Inc. Acquires ChoiceSpine, LP

Completes third acquisition in less than two years and second in the medical technology industry Altus Capital Partners, Inc. (“Altus”), an investment firm focused ...

WuXi Biologics' Chief Quality Officer Received Foreign Post Service Award from FDA

SHANGHAI, Sept. 17, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development...

WuXi Biologics Announced Exclusive Discovery Research with Brii Biosciences for Novel ...

SHANGHAI, Dec. 9, 2018 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development a...

Key Biologics merges with Astarte Biologics

In conjunction with the merger the new entity also received an investment from Ampersand Capital Partners to continue expanding the company in the rapidly evolving cell and gene therapy The post Key...

Drugs and Medications [8 Associated Drugs and Medications listed on BioPortfolio]

Urea [exact-rx, inc.]

Urea Nail Gel 45% (in a vehicle containing camphor, menthol and eucalyptus oil) Rx Only

Atryn [revo bioloigics, inc.]

These highlights do not include all the information needed to use ATryn safely and effectively. See full prescribing information for ATryn. ATryn, Antithrombin (Recombinant) Lyophilized powder for rec...

Urea [exact-rx, inc.]

Urea Cream 45%

Anticoagulant citrate dextrose a [citra labs]

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3

Rejuvesol [citra labs llc]

rejuvesol red blood cell processing solution

PubMed Articles [98 Associated PubMed Articles listed on BioPortfolio]

Associations between multiple immunosuppressive treatments before surgery and surgical morbidity in patients with ulcerative colitis during the era of biologics.

It is unclear whether immunomodulators or biologics, with the exception of corticosteroids, can be risk factors for postoperative infectious complications of ulcerative colitis (UC). Moreover, many im...

Considerations for implementing an informatics system to support biologics drug discovery.

A comprehensive, well-functioning and scientifically aware informatics environment is of the utmost importance in supporting effective drug discovery programs. However, implementing such a system can,...

Use of Population Pharmacokinetic Analyses Among FDA-Approved Biologics.

Biologics, especially monoclonal antibodies, are increasingly important in the pharmaceutical marketplace. Population pharmacokinetic (PK) analyses could be useful to guide the need for dose adjustmen...

Advanced formulations for Intranasal Delivery of Biologics.

The global biologics market has been ever increasing over the last decades and is predicted to top Euro 350 by 2020. Facing this scenario, the parenteral route of biologics administration as hitherto ...

Dose Increase beyond Labelled Dose of Biologics Is Associated With Incremental Pharmacy Costs: Results from a Real-World Study In the UK.

Evidence regarding dosing patterns of biologics among moderate to severe psoriasis patients and impact on costs in the United Kingdom (UK) is limited.

Clinical Trials [84 Associated Clinical Trials listed on BioPortfolio]

A Study Comparing Biologics + Methotrexate With Biologics + Tacrolimus in Patients With Rheumatoid Arthritis (RA)

The purpose of this study is to compare the efficacy of Biologics + Methotrexate with Biologics + Tacrolimus measured by the disease activity score 28 (DAS28) erythrocyte sedimentation rat...

Ustekinumab Safety and Surveillance Program Using the Ingenix NHI Database

The patients included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health plan...

Golimumab Safety and Surveillance Program Using the Ingenix NHI Database

The participants included in this observational study will be drawn from a research database containing claims and enrollment data for members of a large, geographically diverse US health ...

Real World Effectiveness of Ustekinumab in Induction and Maintenance Therapy for Crohn´s Disease

"RUN-CD" is an investigator initiated "Non interventional Trial" on biologics in Crohn´s Disease (CD) patients in Germany with a prospective documentation of effectiveness in induction an...

Tight Control Dose Reductions of Biologics in Psoriasis Patients With Low Disease Activity

Rationale/hypothesis: Moderate-to-severe psoriasis can be treated with biologics. Objective To investigate whether the dose of biologics can be reduced in patients with psoriasis with sta...

Companies [315 Associated Companies listed on BioPortfolio]

Altus Biologics

Altus is a leading life sciences company, which has developed a unique, powerful and proprietary platform technology, known as Crystalomics™, to enable the rapid commercialization of high-value prot...

Altus Biologics Incorporated

Altus is a leading life sciences company, which has developed a unique, powerful and proprietary platform technology, known as Crystalomics™, to enable the rapid commercialization of high-value prot...

Altus Pharmaceuticals Inc.

Altus® Pharmaceuticals is focused on developing and commercializing novel protein therapeutics for patients with chronic gastrointestinal and metabolic diseases. Altus' in-depth knowledge of protein ...

Altus Capital Partners, Inc.

Altus Capital Partners is a private equity firm that makes control investments in middle market manufacturing businesses. We believe that our exclusive focus on manufacturing prov...

ABEC and WuXi Biologics

WuXi Biologics, a Hong Kong-listed company, is the only open-access biologics technology platform in the world offering end-to-end solutions to empower organizations to discover d...